Clinical Trial Update: Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating A-319 for active or refractory systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• A-319

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING